Posts Tagged ‘NSTEMI’
NSTEMI Guidelines: Are the US and Europe in Harmony?
Posted by: admin on: November 21, 2011
At the ESC meeting in Paris, the new European guidelines on non-ST-segment elevation myocardial infarction were released. -Team@CMHF The updated ACCF/AHA guidelines came out in March 2011. While there is concordance for early invasive management, there are subtle differences relating to adjunctive pharmacologics. For one, ticagrelor was not included in the US update since it […]
Antiplatelet Therapy in the Elderly Patient with ACS
Posted by: admin on: November 2, 2011
Since elderly population is increasing and ischemic heart disease being the leading cause of mortality. The number of patients with ACS and ACS-related morbidities will continue to increase as the proportion of older persons increases. Because of the fear of complications like bleeding, this group are undertreated. A study with a focus on antiplatelet and […]
New ESC Guidelines Recommend Efient® (Prasugrel) as First-line Antiplatelet Therapy for Patients with Non-ST Segment Myocardial Infarction and Unstable Angina Acute Coronary Syndromes
Posted by: admin on: September 19, 2011
In new guidelines from the European Society of Cardiology (ESC), Prasugrel – a once daily oral antiplatelet medicine – received a Class I recommendation for use in patients undergoing percutaneous coronary intervention (PCI) after experiencing a non-ST-segment elevation acute coronary syndrome (which comprises non-ST segment elevation myocardial infarction or NSTEMI – a type of heart […]
Search
- drchasrani: Difficult to get such a data, authenticated at that. Try Times of India online library
- rakesh pore: hi, where can i get genuine information about "10 most common drugs sold in india?" i want it for a local project
- nilesh dutta: sir, Plz give detail about MBA Sports Management Thanks and Regards
